respiratory
Community-Acquired Pneumonia (CURB-65)
Risk stratification and antibiotic selection for community-acquired pneumonia using CURB-65
Source: BTS 2009 / NICE NG138
Step 1 of ~6
info
CAP Assessment
Confirm diagnosis: new consolidation on CXR + ≥2 of: cough, fever, pleuritic pain, dyspnoea, signs on examination.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Lefamulin · Pleuromutilin Antibiotic (Community-Acquired Pneumonia)
- Amoxicillin · Antibiotic — Community-Acquired Pneumonia
- Ceftriaxone (Paediatric) · Third-Generation Cephalosporin — Meningitis / Sepsis / Community-Acquired Pneumonia
- Doxycycline 100mg (Acne / Rosacea) · Oral tetracycline antibiotic (anti-acne / anti-rosacea)
- Lymecycline 408mg (Acne) · Oral tetracycline antibiotic (anti-acne)
- Erythromycin 2% Topical · Topical macrolide antibiotic (anti-acne)
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
- Acute Pulmonary Embolism · BTS 2003 / ESC 2019
- Pleural Effusion Assessment · BTS 2010
- Oxygen Prescribing · BTS 2017
Decision support only. Always apply local guidelines and clinical judgement.